Ether hydrochloride → 1-{3-[6,7-Bis(2-methoxyethoxy)quinazolin-4-ylthio]phenyl}-3-(5-tert-butylisoxazol-3-yl)urea hydrochloride
Reaction equation
[CH3:1][O:2][CH2:3][CH2:4][O:5][C:6]1[CH:7]=[C:8]2[C:13](=[CH:14][C:15]=1[O:16][CH2:17][CH2:18][O:19][CH3:20])[N:12]=[CH:11][N:10]=[C:9]2[S:21][C:22]1[CH:23]=[C:24]([NH:28][C:29]([NH:31][C:32]2[CH:36]=[C:35]([C:37]([CH3:40])([CH3:39])[CH3:38])[O:34][N:33]=2)=[O:30])[CH:25]=[CH:26][CH:27]=1.[ClH:41].CCOCC>C(Cl)Cl.CO>[ClH:41].[CH3:1][O:2][CH2:3][CH2:4][O:5][C:6]1[CH:7]=[C:8]2[C:13](=[CH:14][C:15]=1[O:16][CH2:17][CH2:18][O:19][CH3:20])[N:12]=[CH:11][N:10]=[C:9]2[S:21][C:22]1[CH:23]=[C:24]([NH:28][C:29]([NH:31][C:32]2[CH:36]=[C:35]([C:37]([CH3:40])([CH3:39])[CH3:38])[O:34][N:33]=2)=[O:30])[CH:25]=[CH:26][CH:27]=1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
As described in Example 6B Step 2, to a solution of 1-{3-[6,7-bis(2-methoxyethoxy)quinazolin-4-ylthio]phenyl}-3-(5-tert-butylisoxazol-3-yl)urea in CH2Cl2 and MeOH was added 1.0 M HCl/Et2O solution (2 eq.), to afford 1-{3-[6,7-bis(2-methoxyethoxy)quinazolin-4-ylthio]phenyl}-3-(5-tert-butylisoxazol-3-yl)urea hydrochloride as solid (0.098 g, 40%). 1H NMR (300 MHz, DMSO-d6) δ 9.66 (s, 1H), 9.23 (s, 1H), 8.72 (s, 1H), 7.85 (s, 1H), 7.52 (d, 1H), 7.44 (t, 1H), 7.44 (s, 1H), 7.38 (s, 1H), 7.28 (d, 1H), 6.49 (s, 1H), 4.35 (m, 4H), 3.78 (m, 4H), 3.37 (s, 3H), 3.35 (s, 3H), 1.28 (s, 9H); LC-MS (ESI) m/z 568 (M+H)+.
Sources & evidence
- ORD record
- ord-51d5d4ff16804ee89addb1e2ca336ef0
- Source dataset
- uspto-grants-2015_03
- Patent number
- US08969587B2
Reaction notes
Loading…